Summary
The goal of this study is to conduct a prospective, longitudinal natural history study of children and adults with Angelman Syndrome using investigator-observed and parent-reported outcome measures to obtain data that will be useful for future clinical trials.
Conditions
Angelman Syndrome
Recruitment Status
Recruiting
Detailed Description
The overall goal is to increase our understanding of the long-term natural history of Angelman syndrome and obtain Angelman-specific norms for outcome measures that can be used in clinical trials, ultimately improving the care of individuals with Angelman syndrome.
Eligibility Criteria
Inclusion Criteria:
Molecular diagnosis of Angelman syndrome
Exclusion Criteria:
Presence of another condition, unrelated to Angelman syndrome, that affects neurodevelopment
Gender
All
Min Age
N/A
Max Age
N/A
Download Date
August 1, 2023
Principal Investigator
This field has been modified from ClinicalTrials.gov to show a contact specific to Boston Children's.
Primary Contact Information
Lotus.Lichty@childrens.harvard.edu
617-919-2536
This field has been modified from ClinicalTrials.gov to show a contact specific to Boston Children's.
For more information on this trial, visit clinicaltrials.gov.
Contact
For more information and to contact the study team: